Helping you improve the lives of people living with immunological conditions.

UCB’s ambition is to improve the lives of people living with severe diseases.

Alongside our proven therapies we have invested in this resource to support your drive for optimal patient outcomes, accredited education, practice insights and clear concise treatment data. 

We have teamed up with a variety of specialist healthcare professionals and experts to bring you the most relevant data and advice for your field. 


What's on UCB connect


CPD certified content

Head to the Rheumatology and Dermatology pages for: 

Live webinars | Podcasts | Expert videos | Reports | Learning modules | Useful materials


Product information

Head to the treatments page for:

Key study summaries | Efficacy overviews | Safety profile information | Dosing and administration guides | Molecular structure information | Order patient materials 


Connect with us

Contact us

Arrange a meeting with a UCB representative or UCB Medical Information


What's new

Evolution in Rheumatology for Nurses Highlights 2022
Date of preparation: June 2022 | IE-P-CZ-axSpA-2200048

  • Fertility ‒ What is the Impact?
  • Shared Decision-Making Around Family Planning
  • The Future of Specialist Nursing
  • Rheumatology Nursing Moving Forward

Modules presented by:
Dr Maria Mouyis, Dr Iona Thorne, Professor Alison Leary MBE and Ms Alison Kent

Evolution in Rheumatology for Nurses Highlights 2022

Evolution in Rheumatology for Nurses Highlights 2022
Orbit 360 enabled
Orbit 360 Tags Ref

Why connect with UCB connect?

Register with UCB Connect
  • Access to in-depth professional insight, opinion and content created by healthcare professionals, through webinars, podcasts, case studies and more
  • Keep track of your learning progress by earning CPD certification and downloading your own Reflective Learning Guides
  • Support for you and your continued professional development
Because we're in this together...

Report adverse events

Adverse events should be reported. Reporting forms and information can be found at and

Adverse events should also be reported to UCB Pharma Ltd Email: and

Feature requests

Help us to grow our resource the way you want it to grow.

Get in touch now

Date of preparation: July 2023